Cevimeline HCL 30 MG capsule 100S
Ended Awarded
- Contract number
- SPE2DB26FJMNB
- Awardee
-
Dakota Drug, Inc. UEI H544BCGUKW64
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,008
Award facts
- Contract value 100% obligated
- $1,008.49 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Anoka, MN, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $1,008.49 to Dakota Drug, Inc. for Cevimeline HCL 30 mg capsules (100 count) on October 28, 2025, with completion targeted for October 29, 2025. This delivery order was issued under firm fixed-price terms with no set-aside designation and represents a routine pharmaceutical procurement supporting U.S. Armed Forces medical operations. The work will be performed in Anoka, Minnesota, where Dakota Drug maintains its headquarters.
This delivery order is executed as an individual task order under Dakota Drug's larger single-award Indefinite Delivery Contract (IDC SPE2DB24D8001), a $999,999,999.00 vehicle awarded by the Defense Logistics Agency on June 6, 2024, through the DLA Troop Support Medical's ECAT Generation V Program. The parent IDC authorizes procurement of commercial medical equipment, accessories, consumables, and medical simulation equipment supporting the entire Department of Defense healthcare system through December 31, 2025. Dakota Drug, a self-certified small disadvantaged business operating as a Subchapter S Corporation since 2001, serves as the sole awardee under this strategic medical supply contract, demonstrating its critical role within the military medical supply chain for delivering diverse pharmaceutical products across multiple therapeutic categories to defense healthcare facilities.
Quick answers
Who was awarded contract SPE2DB26FJMNB?
SPE2DB26FJMNB was awarded to Dakota Drug, Inc. by Defense Logistics Agency (Department of Defense) on October 28, 2025.
How much is contract SPE2DB26FJMNB worth?
The government has obligated $1,008 on SPE2DB26FJMNB.
Is contract SPE2DB26FJMNB an order under another contract?
Yes. SPE2DB26FJMNB is a delivery order under SPE2DB24D8002, an indefinite delivery contract.
Was contract SPE2DB26FJMNB competed?
The extent of competition for SPE2DB26FJMNB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award